Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesPrimary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammationCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisKynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous SystemProtective actions of ovarian hormones in the serotonin system of macaquesKynurenine Pathway Activation in Human African TrypanosomiasisKynurenine pathway metabolites in humans: disease and healthy States.Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.Kynurenic acid in plasma and endometrium in bitches with pyometra.Analysis of the wild-type and mutant genes encoding the enzyme kynurenine monooxygenase of the yellow fever mosquito, Aedes aegypti.Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progressionUnderstanding the roles of the kynurenine pathway in multiple sclerosis progression.The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications.NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach.On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in ratsMetabolic pathways as possible therapeutic targets for progressive multiple sclerosis.Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid.Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients.Reply to: kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms?New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.Modulation of Tryptophan and Serotonin Metabolism as a Biochemical Basis of the Behavioral Effects of Use and Withdrawal of Androgenic-Anabolic Steroids and Other Image- and Performance-Enhancing Agents.Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases?Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis.
P2860
Q21129356-C70B482A-6779-4AAD-82AF-BBDBE27738DAQ25256714-37C6CFA6-7E97-4537-AE7D-E6B1D7212DE0Q26740330-BC5BFC70-D2CB-444E-BE79-E32439134E14Q26796667-72F19C0C-1E4D-4FDA-94C1-D6D217AE8484Q33435072-A9D2E37E-C4DF-4CEF-BC19-9CA607F21101Q33553777-B0D1DCAD-E90B-4AB6-8863-222D721D14F6Q34633683-B122FB65-5B0F-4333-994B-BE72FBF1FEACQ34997869-FBF9047B-F0AB-4CE0-9E7E-34EC44092E72Q36554693-FC9E00EB-0F86-49AC-AF68-82B299F8BAE4Q37069350-A241C48D-2F07-49A0-97CA-ABF425BAAE07Q37460122-38BEE658-090E-49C8-A2C8-AE4289E4F538Q37623145-88D6B6F0-C891-4E0F-A632-E95A6BB26A35Q37956307-F75226A1-2211-4FEE-BC27-FD50758F0D37Q37977023-A2E3A29F-62B0-4FF4-921C-807ED23AF75CQ37984791-9BABD992-078D-4680-AB7A-AE8D3A7E1FDDQ38575783-D5280388-7C77-4DE5-9C09-757AE8F1DD16Q41139088-0EB97BE8-34F7-4BB1-BD84-FD682C90AEB6Q42161912-98AC1581-F2B8-408D-B7B4-9325A168DDFEQ42361828-2C194E9C-FE53-4EE2-9B34-BDF0ED21651CQ43627935-C1087B7B-7CA9-4BB3-86AB-4C19C9398770Q43718624-4F97B0FF-1366-4318-A9C2-3A9EF42109D7Q44158595-D88FF272-DC88-445A-A6E8-B660014DC5ABQ46625958-03EF0751-D091-4116-8FAC-D62AC85C8CF2Q47865980-06EAB8AC-AF8C-4288-85A4-F4C9B85FED79Q48854001-20132F12-2657-4620-A71E-273FA8EA3743Q50334911-D7A238C8-A7E4-4AAB-9D7F-8FE8BF302FADQ51165149-6FCCFCAA-03B4-4986-8E44-14174ED3A9F6Q54755426-5AC91B47-E351-4678-96E5-3104BB84E195Q55188589-CE3D3E26-23A3-4D0B-ACC9-E41C81A1D5D6
P2860
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Kynurenine 3-mono-oxygenase ac ...... al allergic encephalomyelitis.
@ast
Kynurenine 3-mono-oxygenase ac ...... al allergic encephalomyelitis.
@en
type
label
Kynurenine 3-mono-oxygenase ac ...... al allergic encephalomyelitis.
@ast
Kynurenine 3-mono-oxygenase ac ...... al allergic encephalomyelitis.
@en
prefLabel
Kynurenine 3-mono-oxygenase ac ...... al allergic encephalomyelitis.
@ast
Kynurenine 3-mono-oxygenase ac ...... al allergic encephalomyelitis.
@en
P2093
P1433
P1476
Kynurenine 3-mono-oxygenase ac ...... al allergic encephalomyelitis.
@en
P2093
P304
P356
10.1016/S0306-4522(00)00504-2
P407
P577
2001-01-01T00:00:00Z